ArticleCancer research2014

Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges.

Dominique B Hoelzinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.